Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous malignancy in albinism.

P K Perry1, N B Silverberg

  • 1Department of Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Suite 11D, New York, NY 10025, USA.

Cutis
|May 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of atopic dermatitis with poor school behaviours in US children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Association of vitiligo with hospitalization for mental health disorders in US adults.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.

The British journal of dermatology·2016
Same author

Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study.

The British journal of dermatology·2015
Same author

Response to 'Assessment of vitiligo severity: patient-reported estimates are not accurate'.

The British journal of dermatology·2015
Same author

Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study.

The British journal of dermatology·2014
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Patients with albinism have a higher risk of skin cancer due to reduced melanin. Hypopigmented lesions, like squamous cell carcinoma and amelanotic melanoma, can delay diagnosis in these individuals.

Area of Science:

  • Dermatology
  • Oncology
  • Genetics

Background:

  • Albinism is a genetic disorder characterized by hypopigmentation of the skin, hair, and eyes.
  • Reduced melanin in albinism offers little protection against ultraviolet (UV) radiation, increasing the risk of skin cancers.
  • Squamous cell carcinoma (SCC) is the most prevalent skin malignancy in individuals with albinism.

Observation:

  • This report details two cases of cutaneous malignancies in patients with oculocutaneous albinism (OCA).
  • Case 1: A 45-year-old male with OCA type 2 (OCA2) developed a large SCC on his neck.
  • Case 2: A 24-year-old male with Hermansky-Pudiak syndrome (HPS) was diagnosed with amelanotic melanoma.

Findings:

  • The hypopigmented nature of these skin lesions, including dysplastic nevi and melanomas, poses diagnostic challenges.

Related Experiment Videos

  • In both reported cases, the lack of pigmentation in the malignancies contributed to delayed diagnosis.
  • Both SCC and amelanotic melanoma require careful clinical evaluation in patients with albinism.

    • Implications:

    • Early and accurate diagnosis of skin cancers in albinism is crucial for effective treatment and improved patient outcomes.
    • Increased awareness and specialized diagnostic approaches are necessary for managing cutaneous malignancies in individuals with albinism.
    • Further research into the specific oncogenic pathways and tailored therapeutic strategies for albinism-related skin cancers is warranted.